How Global Chemistry and Geopolitics Triggered a Fentanyl Supply Shock and Decline in Overdose Mortality

Abstract

The trajectory of the American opioid epidemic, a public health catastrophe that has claimed over a million lives since the turn of the millennium, has historically been defined by a grim and relentless ascent. From the prescription pill mills of the early 2000s to the heroin surge of the 2010s and the synthetic saturation of the 2020s, the mortality curves have pointed inexorably upward. However, provisional data emerging from the Centers for Disease Control and Prevention (CDC) for the year 2024 has revealed a statistical anomaly of historic proportions: a sudden, precipitous decline in drug overdose deaths, projected to be nearly 27% lower than the preceding year. This report investigates the multi-factorial causality behind this unprecedented contraction. By triangulating provisional mortality data, seizure statistics, and diplomatic records, we posit that this decline is the downstream result of a "supply shock"—a systemic disruption in the global precursor chemical trade triggered by the resumption of counternarcotics cooperation between the United States and the People's Republic of China in late 2023. This analysis explores the chemical vulnerabilities of the "Siegfried method" of fentanyl synthesis, the logistical fragility of "Just-in-Time" transnational trafficking, and the concurrent impact of domestic harm reduction saturation. We further evaluate the durability of this downturn against the theoretical framework of the "Iron Law of Prohibition" and the looming threat of novel synthetic opioids such as nitazenes.

Part I: The Architecture of the Fentanyl Crisis

1.1 The Synthetic Paradigm Shift

To comprehend the magnitude of the 2024 decline, it is necessary to first excavate the structural foundations of the crisis it interrupted. The modern opioid epidemic is distinct from historical drug scourges not merely in its scale, but in its industrial character. The shift from plant-based narcotics—such as heroin derived from the opium poppy (Papaver somniferum) and cocaine from the coca leaf—to synthetic opioids represented a revolution in the economics of illicit drug markets.

For decades, the global heroin trade was tethered to the agricultural cycle. It was vulnerable to climatological events, such as droughts in Afghanistan or blight in the Golden Triangle. It was susceptible to aerial eradication campaigns and required vast territories of land, armies of peasant labor, and complex, physical supply lines to move bulky raw materials to processing centers. The introduction of illicitly manufactured fentanyl (IMF) decoupled the drug trade from the land.¹

Fentanyl is a product of the laboratory, not the field. Its production is constrained only by the availability of precursor chemicals and the technical competence of clandestine chemists. The economic incentives for this transition were overwhelming. Fentanyl is approximately 50 to 100 times more potent than morphine. This extreme potency translates into extreme logistical efficiency; a kilogram of fentanyl, which can be synthesized in a kitchen-sized laboratory, is equivalent in potency to dozens of kilograms of heroin. For transnational criminal organizations (TCOs), this meant that the product could be moved in smaller parcels—hidden in the spare tires of passenger vehicles, concealed within legitimate commercial cargo, or even mailed in standard envelopes—drastically reducing the risk of interdiction while maximizing profit margins.²

By 2023, this synthetic paradigm had achieved total market saturation. The CDC estimated that over 110,037 Americans died from drug overdoses in that year alone, with synthetic opioids involved in nearly 70% of those fatalities.⁴ Fentanyl had ceased to be merely an adulterant found in heroin; it had become the primary commodity, pressed into counterfeit pills resembling pharmaceutical oxycodone ("M30s"), Xanax, or Adderall, and sold to a consumer base that ranged from long-term opioid users to experimental adolescents. The crisis had become a demographic scythe, cutting across lines of race, class, and geography, with particularly devastating impacts on Black and American Indian/Alaska Native populations who had been historically underserved by addiction medicine.⁶

1.2 The Plateau of Despair (2019-2023)

The years immediately preceding the 2024 shock were characterized by a sense of fatalism in public health policy. Despite the implementation of prescription monitoring programs, the expansion of medication-assisted treatment (MAT), and the deployment of naloxone, the death toll continued to rise. The "Iron Law of Prohibition"—a term coined by activist Richard Cowan in 1986—seemed to be operating with ruthless efficiency. The law posits that as law enforcement becomes more intense, the potency of prohibited substances increases. Smugglers prefer more potent drugs because they are more compact and easier to hide. Just as alcohol prohibition led to the rise of moonshine over beer, the crackdown on prescription pills and heroin had birthed the fentanyl era.⁸

In 2022 and 2023, the market appeared to have reached a grim stability. The western United States, which had historically been insulated from the worst of the white-powder fentanyl characteristic of the East Coast due to the dominance of "black tar" heroin, saw a massive influx of fentanyl pills. The "blues" flooded markets in Washington, Oregon, and California, driving overdose rates in those states to vertical ascents.¹⁰ The supply chain, stretching from chemical factories in Hubei province to super-labs in Sinaloa and finally to street corners in Philadelphia and San Francisco, seemed invulnerable.

Then, in early 2024, the numbers began to turn.

Part II: The Chemistry of Control

The vulnerability of the synthetic opioid market lies in its very nature: it is a chemical industry. Unlike a weed that can grow in a ditch, fentanyl must be made. Its existence is contingent upon a specific sequence of molecular interactions, requiring specific reagents that are not easily substituted. This chemical dependency creates "choke points"—nodes in the supply chain where the disruption of a single input can arrest the entire production process.

2.1 The Siegfried Method: A Clandestine Standard

To understand the supply shock, one must understand the method of manufacture. While there are multiple synthetic routes to fentanyl, clandestine laboratories are driven by the need for speed, simplicity, and yield. They overwhelmingly favor a synthesis pathway known as the "Siegfried Method."

The Siegfried method, named after the pseudonym of a clandestine chemist who popularized it on internet forums in the late 1990s, is a three-step process that bypasses the more complex and heavily regulated precursors required by the pharmaceutical "Janssen Method".¹²

Step 1: The Backbone. The synthesis begins with N-phenethyl-4-piperidone (NPP). This molecule provides the structural "skeleton" of the fentanyl molecule—the piperidine ring attached to a phenethyl group.

Step 2: Reductive Amination. The NPP is reacted with aniline (phenylamine) in the presence of a reducing agent (typically sodium borohydride or similar hydride donors). In this reaction, the oxygen atom double-bonded to the piperidine ring is stripped away and replaced by the aniline group. This produces the critical intermediate: 4-anilino-N-phenethylpiperidine (4-ANPP).¹²

Step 3: The Acylation. In the final step, the 4-ANPP is treated with propionyl chloride (or propionic anhydride). This reaction attaches a propionyl chain to the nitrogen atom of the aniline group. The result is Fentanyl (N-(1-(2-phenethyl)-4-piperidinyl)-N-phenylpropanamide).¹⁵

2.2 The Precursor Shell Game

The strategic importance of NPP and 4-ANPP cannot be overstated. They are the essential bottlenecks. Recognizing this, international bodies moved to control them. In 2017, the United Nations Commission on Narcotic Drugs placed NPP and 4-ANPP on Table I of the 1988 Convention. China, complying with this international consensus and pressure from the United States, listed them as controlled substances in 2018.¹⁶

However, the chemical industry is adaptive. When the front door was closed, manufacturers opened a side window. They began producing "masked precursors" or "designer precursors."

A masked precursor is a chemical that is one simple reaction away from being a controlled precursor. By adding a chemical "mask"—a protecting group—to the molecule, suppliers could create a substance that was chemically distinct from the banned list, and thus technically legal to export.

The most prevalent example in the lead-up to the 2024 shock was 1-boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate). To a customs inspector or a mass spectrometer programmed to detect 4-ANPP, this molecule appeared benign. It was sold under the guise of being a generic chemical intermediate. However, once this substance reached a laboratory in Mexico, the chemist simply had to treat it with an acid. The acid would "cleave" or remove the "boc" protecting group, instantly converting the legal chemical back into the banned 4-ANPP, ready for the final step of fentanyl synthesis.¹⁶

Suppliers also moved further upstream, utilizing 4-piperidone (a common chemical used in various legitimate industries) to synthesize NPP from scratch, adding another layer of obfuscation to the supply chain.¹² This cat-and-mouse game allowed the flow of fentanyl materials to continue unabated from 2019 through 2023, despite the nominal bans on the books.

Part III: The Geopolitical Pivot

The supply shock of 2024 was not a result of a new chemical discovery, but of a political breakthrough. The flow of precursors from China to Mexico had thrived in the vacuum of US-China counternarcotics cooperation. Following geopolitical tensions related to trade, human rights, and the visit of then-Speaker Nancy Pelosi to Taiwan, Beijing had formally suspended bilateral counternarcotics dialogue in August 2022.¹⁹ During this freeze, Chinese chemical vendors operated with relative impunity, selling precursors openly on B2B e-commerce platforms.

3.1 The Woodside Summit (November 2023)

The turning point occurred in November 2023, at the summit between President Joe Biden and President Xi Jinping at the Filoli estate in Woodside, California. Amidst high-stakes discussions on military communications and Taiwan, the fentanyl crisis was a central agenda item.

The diplomacy involved a transactional exchange. The United States removed the Chinese Ministry of Public Security’s Institute of Forensic Science from the Department of Commerce’s "Entity List"—a trade blacklist where it had been placed due to alleged complicity in human rights abuses in Xinjiang. In return, President Xi committed to a substantive restart of counternarcotics cooperation and a crackdown on the export of precursor chemicals.¹⁹

3.2 The "Notice" and the Crackdown

Unlike previous agreements which often resulted in vague commitments, the 2023 summit spurred immediate administrative action within China. The Chinese National Narcotics Control Commission (NNCC) issued a "Notice" to the domestic chemical industry. This document was pivotal. It explicitly warned Chinese companies that they must ensure their products were not being used for illicit purposes and cautioned them against selling substances that were controlled in the United States and Mexico, even if those substances were not yet fully controlled in China.²¹

The Notice was accompanied by an appendix listing 51 precursors controlled by the U.S., effectively closing the "masked precursor" loophole. For a chemical broker in Wuhan or Shanghai, the message was clear: the state protection for this grey-market trade had been withdrawn.

3.3 The Chilling Effect

The impact of this administrative shift was amplified by targeted law enforcement. In late 2023 and early 2024, the U.S. Department of Justice unsealed indictments against several Chinese chemical companies and their executives, such as Hubei Aoks Bio-Tech Co. Ltd..²² These indictments detailed how companies had knowingly shipped precursors to Mexican cartels, mislabeling them as "vases," "furniture parts," or "makeup" to evade customs.²²

Simultaneously, reports surfaced that Chinese authorities were taking down websites and blocking payment accounts associated with precursor sales.¹⁹ The "chilling effect" was profound. The risk-to-reward ratio for selling 4-ANPP or its masked variants shifted dramatically. The "just-in-time" supply chain, which relied on the easy, open purchase of these chemicals, began to fracture.

Part IV: The Logistics of the Supply Shock

The efficacy of the political crackdown was magnified by the logistical structure of the modern drug cartel. The Sinaloa Cartel and the Jalisco New Generation Cartel (CJNG) had adopted the efficiency models of legitimate global logistics, specifically "Just-in-Time" (JIT) inventory management.²³

4.1 The Fragility of JIT Trafficking

In a JIT system, inventory is kept to a minimum to reduce costs and liabilities. For a drug cartel, stockpiling tons of precursor chemicals is a liability. It requires large warehouses that are vulnerable to raids; it ties up capital in raw materials; and the chemicals themselves are often volatile, toxic, and difficult to store safely. Instead, cartels preferred a steady stream of shipments—containers arriving weekly or monthly at ports like Manzanillo or Lazaro Cardenas, or air cargo shipments landing in Mexico City.²⁴

This efficiency created a vulnerability. The system lacked resilience. When the Chinese crackdown throttled the flow of precursors in late 2023, the cartels did not have massive strategic reserves to fall back on. The "pipeline" dried up.

4.2 Indicators of Scarcity

The evidence of this supply shock began to appear in the data in early 2024.

• Seizure Data: U.S. officials noted a reduction in the volume of precursors being seized at airports, suggesting fewer attempts were being made to ship the chemicals.²¹

• Purity Fluctuations: In times of scarcity, drug suppliers typically "cut" their product more aggressively to stretch their limited inventory. While granular data on street-level purity is often delayed, anecdotal reports and law enforcement intelligence suggested a destabilization in the consistency of the fentanyl supply.¹⁰

• The Overdose Decline: The ultimate indicator was the drop in deaths. The lag time between the November 2023 summit and the steep drops in mortality in early-to-mid 2024 is consistent with the time it takes for existing stockpiles of finished fentanyl to move through the distribution chain and be consumed. Once the "pipeline" emptied, the shortage hit the street.²⁶

Part V: The Domestic Response and Harm Reduction

While the supply shock provides a compelling explanation for the suddenness of the decline, it is unlikely to be the sole cause. The 2024 contraction occurred against a backdrop of unprecedented domestic efforts to reduce overdose mortality. The supply shock likely acted as a force multiplier for these existing interventions.

5.1 Naloxone Saturation

By 2023 and 2024, the distribution of naloxone (the opioid reversal agent) had reached saturation levels in many high-risk communities. Fueled by federal grants and the payouts from multi-billion dollar legal settlements with opioid manufacturers and distributors, states flooded their communities with the life-saving drug.

Case Study: Ohio. Ohio, long an epicenter of the crisis, saw one of the most significant declines in overdose deaths in 2024 (projected at over 30%).⁵ This correlates with the aggressive "RecoveryOhio" initiative. In 2023 alone, the program distributed over 291,000 naloxone kits. The state integrated naloxone distribution into emergency rooms, health departments, and even vending machines.²⁸

This creates a divergence between "overdose events" and "overdose deaths." It is possible that the number of people overdosing did not drop as precipitously as the death count, but that a higher percentage of those overdoses were successfully reversed due to the ubiquity of naloxone. The supply shock may have reduced the potency of the drugs (making overdoses easier to reverse), while the naloxone saturation ensured the means of reversal were at hand.³⁰

5.2 Behavioral Adaptation and Risk Environment

The concept of the "Risk Environment" helps explain the resilience of drug-using communities. After years of high mortality, social norms within these communities began to shift. The use of fentanyl test strips became more common, as did the practice of not using drugs alone. State data from Massachusetts indicates that while non-fatal overdoses remained a challenge, the lethality was being mitigated by these behavioral changes supported by harm reduction infrastructure.³¹

Part VI: The Xylazine Complication

A confounding variable in the 2024 data is the rise of xylazine. Known on the street as "tranq," xylazine is a veterinary sedative that has been increasingly used as an adulterant in the fentanyl supply.

6.1 The Adulterant of Scarcity?

The relationship between xylazine and the overdose decline is complex and seemingly paradoxical. Xylazine causes severe morbidity—horrific skin ulcers, necrosis, and heavy sedation—and it renders naloxone partially less effective because the sedation from xylazine is not reversed by the opioid antagonist.³²

However, some toxicological theories suggest that the displacement of fentanyl by xylazine might, in specific circumstances, reduce immediate overdose lethality. If a pill contains 50% less fentanyl because the supplier "bulked it up" with cheap xylazine due to the precursor shortage, the risk of immediate respiratory arrest—the primary mechanism of opioid death—might decrease, even if the user faces other severe health risks.¹⁰

Data from Connecticut in 2024 showed a rise in xylazine-involved deaths alongside a drop in pure fentanyl deaths.³³ This supports the hypothesis that xylazine is filling the void left by the fentanyl supply shock. It is a grim trade-off: fewer immediate deaths from respiratory failure, but a likely increase in severe soft-tissue infections and complex dependence.

Part VII: The Future and the Iron Law

As promising as the 2024 data appears, the history of drug policy warns against premature celebration. The "Iron Law of Prohibition" suggests that the market will eventually adapt to the new constraints.

7.1 The Nitazene Threat

The most significant threat to the durability of the 2024 decline is the emergence of a new class of synthetic opioids: nitazenes (benzimidazole-opioids).

Nitazenes, such as isotonitazene, protonitazene, and metonitazene, are structurally distinct from fentanyl. They do not contain the piperidine ring structure that relies on NPP and 4-ANPP. Instead, they are synthesized from benzimidazole precursors, which are currently less regulated and have different industrial supply chains.³⁴

Some nitazenes are significantly more potent than fentanyl. Protonitazene, for instance, is estimated to be several times more potent than fentanyl and dozens of times more potent than morphine.³⁵ These substances have already been detected in toxicology reports in Tennessee, Ohio, and the United Kingdom.³⁶

If the shortage of fentanyl precursors persists, the "Iron Law" predicts that cartels will pivot to nitazenes. This would represent a "second wave" of synthetic supply, potentially more lethal than the first, and immune to the specific chemical controls established by the Biden-Xi agreement. The emergence of nitazenes suggests that the "whac-a-mole" dynamic of prohibition is already shifting to the next hole.

7.2 The Durability of Diplomacy

The permanence of the supply shock also rests on the shifting sands of geopolitics. The cooperation of China is a diplomatic concession, not a permanent structural change. If US-China relations deteriorate—over tariffs, Taiwan, or other geopolitical flashpoints—Beijing could tacitly relax its enforcement of the precursor bans. The history of the region suggests that counternarcotics cooperation is often used as a lever in broader statecraft.³⁸ A return to the status quo ante of 2022 would likely see the fentanyl pipeline refill rapidly.

Conclusion

The "Great Contraction" of 2024 represents a rare and significant victory in the decades-long struggle against the opioid epidemic. The data suggests that the decline in deaths was not a random fluctuation, but the result of a coordinated "supply shock" achieved through high-level diplomacy and targeted chemical control. By severing the flow of NPP and 4-ANPP from China, the Biden administration successfully disrupted the "Just-in-Time" supply chains of the Mexican cartels, creating a scarcity that—combined with the heroic saturation of naloxone by domestic public health agencies—saved nearly 30,000 lives in a single year.

However, this victory is fragile. It exists in a precarious equilibrium between chemical scarcity and market adaptation. The rise of xylazine and the looming threat of nitazenes demonstrate that the illicit market is already evolving to bypass the new barriers. The 2024 decline proves that the opioid crisis is not an unstoppable force of nature, but a complex system that can be disrupted. Yet, to make this decline permanent, the strategy must evolve faster than the chemistry of the cartels, moving beyond supply disruption to address the fundamental demand that fuels the engine of the epidemic.

Table 1: Comparative Analysis of Overdose Mortality (Provisional Data 2023-2024)

Source: CDC National Center for Health Statistics ⁵

Substance Category	Estimated Deaths (2023)	Estimated Deaths (2024)	% Change
Total Overdose Deaths	110,037	80,391	-26.9%
Synthetic Opioids (Fentanyl)	76,282	48,422	-36.5%
Psychostimulants (Methamphetamine)	37,096	29,456	-20.6%
Cocaine	30,833	22,174	-28.1%
Natural/Semi-Synthetic Opioids	10,511	8,006	-23.8%

Table 2: Key Precursor Chemicals and Regulatory Status

Source: DEA, UNODC, Federal Register ¹²

Chemical Name	Common Abbreviation	Role in Synthesis	Status
N-phenethyl-4-piperidone	NPP	Primary Backbone (Siegfried Method)	List I Controlled (US/China/UN)
4-anilino-N-phenethylpiperidine	4-ANPP	Immediate Precursor	List I Controlled (US/China/UN)
tert-butyl 4-(phenylamino)piperidine-1-carboxylate	1-boc-4-AP	"Masked" Precursor	List I Controlled (US)
4-piperidone	--	Early Stage Precursor	Watch List / Dual Use
Propionyl Chloride	--	Reagent (Acylation)	Regulated / Dual Use

Table 3: Regional Variation in Overdose Decline (Selected States)

Source: CDC Provisional Data ⁵

State	% Decline (2023-2024)	Context
Ohio	>35%	High Naloxone Saturation ("RecoveryOhio")
Michigan	>35%	Strong Harm Reduction Infrastructure
North Carolina	>30%	Significant Drop in Fentanyl Seizures
Nevada	+ Increase	Counter-trend (West Coast Market Dynamics)
South Dakota	+ Increase	Emerging Market / Lower Baseline

Table 4: Comparative Potency of Opioid Classes

Source: DEA, NIH ³⁵

Substance	Approximate Potency (Relative to Morphine)	Precursor Dependency
Morphine	1x	Opium Poppy
Heroin	2x - 5x	Opium Poppy
Fentanyl	50x - 100x	NPP / 4-ANPP
Carfentanil	10,000x	NPP / 4-ANPP
Isotonitazene	5x - 20x	Benzimidazoles (Non-NPP)
Protonitazene	20x - 60x	Benzimidazoles (Non-NPP)

Works cited

1. What we know about the drownings of 3 Mexican migrants near Eagle Pass, Texas - Congress.gov, accessed January 8, 2026, https://www.congress.gov/118/meeting/house/116759/documents/HMTG-118-IF02-20240117-SD004.pdf

2. No, China isn't really suppressing its production of fentanyl precursors | The Strategist, accessed January 8, 2026, https://www.aspistrategist.org.au/no-china-isnt-really-suppressing-its-production-of-fentanyl-precursors/

3. Fentanyl Continues to Be the Leading Cause of Overdose Deaths. What's Being Done to Combat Trafficking into the United States? - GAO.gov, accessed January 8, 2026, https://www.gao.gov/blog/fentanyl-continues-be-leading-cause-overdose-deaths.-whats-being-done-combat-trafficking-united-states

4. Presidency of Joe Biden - Wikipedia, accessed January 8, 2026, https://en.wikipedia.org/wiki/Presidency_of_Joe_Biden

5. U.S. Overdose Deaths Decrease Almost 27% in 2024 | NCHS Pressroom - CDC, accessed January 8, 2026, https://www.cdc.gov/nchs/pressroom/releases/20250514.html

6. 2024 Drug Overdose Mortality Update - Alaska Department of Health, accessed January 8, 2026, https://health.alaska.gov/media/wqql4fhp/2024-drug-overdose-mortality-update.pdf

7. Michigan's overdose death rate declines nearly five times faster than national average, accessed January 8, 2026, https://www.michigan.gov/mdhhs/inside-mdhhs/newsroom/2024/11/12/overdose-deaths

8. Regulation - Global Commission on Drug Policy, accessed January 8, 2026, https://www.globalcommissionondrugs.org/wp-content/uploads/2018/09/ENG-2018_Regulation_Report_WEB-FINAL.pdf

9. How Iron-Clad Is the Iron Law of Prohibition? - Undark Magazine, accessed January 8, 2026, https://undark.org/2023/10/16/iron-law-drugs/

10. Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths — United States, 2021–2024 | MMWR - CDC, accessed January 8, 2026, https://www.cdc.gov/mmwr/volumes/73/wr/mm7348a2.htm

11. Oregon Health Authority : Fentanyl : Opioid Overdose and Misuse, accessed January 8, 2026, https://www.oregon.gov/oha/ph/preventionwellness/substanceuse/opioids/pages/fentanylfacts.aspx

12. Possible Control of Phenethyl Bromide as a List I Chemical - Regulations.gov, accessed January 8, 2026, https://www.regulations.gov/document/DEA-2024-0134-0001

13. An expanding synthetic drugs market − - Unodc, accessed January 8, 2026, https://www.unodc.org/documents/scientific/Global_SMART_23_web2.pdf

14. 4-ANPP (CRM) (CAS 21409-26-7) - Cayman Chemical, accessed January 8, 2026, https://www.caymanchem.com/product/22700/4-anpp-crm

15. Designation of Propionyl Chloride as a List I Chemical - Regulations.gov, accessed January 8, 2026, https://www.regulations.gov/document/DEA-2023-0138-0008

16. Designation of a List I Chemical: 4-Piperidone - Regulations.gov, accessed January 8, 2026, https://www.regulations.gov/document/DEA-2022-0102-0005

17. China Announces Scheduling Controls On Two Fentanyl Precursor Chemicals - DEA.gov, accessed January 8, 2026, https://www.dea.gov/press-releases/2018/01/05/china-announces-scheduling-controls-two-fentanyl-precursor-chemicals

18. News: April 2022 – UNODC: Three precursors of the most common synthesis routes used in illicit fentanyl manufacture now under international control, accessed January 8, 2026, https://www.unodc.org/LSS/Announcement/Details/b152bda5-5d71-4f7e-9d68-1bdd9af04a83

19. China Primer: Illicit Fentanyl and China's Role - Congress.gov, accessed January 8, 2026, https://www.congress.gov/crs-product/IF10890

20. Entity List Removal - Federal Register, accessed January 8, 2026, https://www.federalregister.gov/documents/2023/11/17/2023-25557/entity-list-removal

21. fentanyl precursors - Congress.gov, accessed January 8, 2026, https://www.congress.gov/crs_external_products/IF/HTML/IF10890.web.html

22. Chinese Chemical Company, Senior Leaders Indicted for Suspected Fentanyl Manufacturing, Distribution | ICE, accessed January 8, 2026, https://www.ice.gov/news/releases/chinese-chemical-company-senior-leaders-indicted-suspected-fentanyl-manufacturing

23. COVID-19, criminal activity and law enforcement Submission 2 - Parliament of Australia, accessed January 8, 2026, https://www.aph.gov.au/DocumentStore.ashx?id=fb2df6f7-9327-42fc-a350-db66938fefd6&subId=690278

24. Artificial Intelligence and Illicit Drugs: A World of Possibilities - Taylor & Francis Online, accessed January 8, 2026, https://www.tandfonline.com/doi/full/10.1080/01639625.2025.2537441

25. Changes in the proportion of fatal overdoses by substance type in the US, 1999–2021, accessed January 8, 2026, https://www.researchgate.net/publication/396140386_Changes_in_the_proportion_of_fatal_overdoses_by_substance_type_in_the_US_1999-2021

26. Products - Vital Statistics Rapid Release - Provisional Drug ... - CDC, accessed January 8, 2026, https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

27. Governor DeWine: Ohio's Overdose Deaths Drop for Second Consecutive Year, Outperforming National Average, accessed January 8, 2026, https://governor.ohio.gov/media/news-and-media/governor-dewine-ohios-overdose-deaths-drop-for-second-consecutive-year-outperforming-national-average

28. Addiction Treatment Statistics in Ohio: What You Need to Know, accessed January 8, 2026, https://www.recreateohio.com/addiction-treatment-statistics-in-ohio/

29. Ohio's Overdose Deaths Drop for Second Year - RecoveryOhio, accessed January 8, 2026, https://recoveryohio.gov/home/news-and-events/all-news/od-death-report-2024

30. What's behind the significant drop in opioid overdose deaths | PBS News, accessed January 8, 2026, https://www.pbs.org/newshour/show/whats-behind-the-significant-drop-in-opioid-overdose-deaths

31. Substance Use and Overdose Data - Mass.gov, accessed January 8, 2026, https://www.mass.gov/lists/substance-use-and-overdose-data

32. Xylazine - National Institute on Drug Abuse (NIDA), accessed January 8, 2026, https://nida.nih.gov/research-topics/xylazine

33. Fatal Unintentional and Undetermined Intent Drug Overdose Report, Connecticut - CT.gov, accessed January 8, 2026, https://portal.ct.gov/-/media/dph/injury-and-violence-prevention/opioid-overdose-data/monthly-death-reports/2019-december-2024_drug-overdose-deaths-monthly-report_connecticut_updated-1-17-2025.pdf

34. THE EMERGENCE OF NITAZENES IN THE AMERICAS - Organization of American States, accessed January 8, 2026, https://www.oas.org/ext/DesktopModules/MVC/OASDnnModules/Views/Item/Download.aspx?type=1&id=1045&lang=1

35. Nitazenes: The Emergence of a Potent Synthetic Opioid Threat - MDPI, accessed January 8, 2026, https://www.mdpi.com/1420-3049/30/19/3890

36. Overdose deaths involving nitazenes seem to be on the rise - American Pharmacists Association, accessed January 8, 2026, https://www.pharmacist.com/Blogs/CEO-Blog/Article/overdose-deaths-involving-nitazenes-seem-to-be-on-the-rise

37. Deaths linked to potent synthetic opioids - GOV.UK, accessed January 8, 2026, https://www.gov.uk/government/publications/deaths-linked-to-potent-synthetic-opioids/deaths-linked-to-potent-synthetic-opioids

38. The US-China fentanyl deal will not stop America's opioid crisis | Lowy Institute, accessed January 8, 2026, https://www.lowyinstitute.org/the-interpreter/us-china-fentanyl-deal-will-not-stop-america-s-opioid-crisis

39. U.S. Overdose Deaths Drop 26.9% in 2024, accessed January 8, 2026, https://pttcnetwork.org/news/u-s-overdose-deaths-drop-26-9-in-2024/

40. Are fentanyl overdose deaths rising in the US? - USAFacts, accessed January 8, 2026, https://usafacts.org/articles/are-fentanyl-overdose-deaths-rising-in-the-us/